We are live on
!
Find out more
MNG
Manning & Napier Group Portfolio holdings
AUM
$8.76B
1-Year Est. Return
23.27%
This Fund
S&P 500
This Quarter
Est. Return
+5.03%
1 Year Est. Return
+23.27%
3 Year Est. Return
+31.12%
5 Year Est. Return
+100.85%
10 Year Est. Return
–
AUM
$11.1B
AUM Growth
–
Cap. Flow
+$10.6B
Cap. Flow
% of AUM
95.54%
Top 10 Holdings %
Top 10 Hldgs %
28.26%
Holding
322
New
293
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$395M |
| 2 |
Meta Platforms (Facebook)
META
|
+$374M |
| 3 |
ServiceNow
NOW
|
+$363M |
| 4 |
Novartis
NVS
|
+$330M |
| 5 |
Unilever
UL
|
+$319M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.11% |
| 2 | Technology | 14.4% |
| 3 | Consumer Discretionary | 11.94% |
| 4 | Industrials | 9.15% |
| 5 | Communication Services | 8.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Medtronic
MDT
$120B
| $398M | 3.58% |
+4,934,563
| New | +$395M |
|
|
2
ServiceNow
NOW
$146B
| $381M | 3.42% |
+14,597,205
| New | +$363M |
|
|
3
Meta Platforms (Facebook)
META
$1.57T
| $373M | 3.35% |
+2,114,294
| New | +$374M |
|
|
4
Novartis
NVS
$304B
| $329M | 2.96% |
+4,375,743
| New | +$330M |
|
|
5
Unilever
UL
$138B
| $313M | 2.82% |
+5,031,911
| New | +$319M |
|
6
DaVita
DVA
$11.7B
| $299M | 2.69% |
+4,143,794
| New | +$255M |
|
7
SLB Ltd
SLB
$85.3B
| $293M | 2.63% |
+4,342,436
| New | +$281M |
|
8
Booking.com
BKNG
$145B
| $284M | 2.55% |
+4,080,900
| New | +$296M |
|
9
Ambev
ABEV
$46.6B
| $240M | 2.15% |
+37,105,336
| New | +$237M |
|
10
Johnson & Johnson
JNJ
$663B
| $234M | 2.1% |
+1,672,815
| New | +$233M |
|
11
Skyworks Solutions
SWKS
$11.1B
| $223M | 2.01% |
+2,352,961
| New | +$245M |
|
12
Visa
V
$700B
| $221M | 1.99% |
+1,941,658
| New | +$214M |
|
13
lululemon athletica
LULU
$11.1B
| $221M | 1.99% |
+2,813,196
| New | +$188M |
|
14
Qorvo
QRVO
$9.07B
| $208M | 1.87% |
+3,126,254
| New | +$228M |
|
15
Mastercard
MA
$507B
| $203M | 1.83% |
+1,341,847
| New | +$200M |
|
16
BioMarin Pharmaceuticals
BMRN
$12.9B
| $177M | 1.59% |
+1,980,877
| New | +$172M |
|
17
Regeneron Pharmaceuticals
REGN
$85.2B
| $171M | 1.54% |
+454,335
| New | +$184M |
|
18
Amazon
AMZN
$2.79T
| $167M | 1.5% |
+2,863,080
| New | +$158M |
|
19
Perrigo
PRGO
$2.07B
| $166M | 1.49% |
+1,905,045
| New | +$164M |
|
20
Howmet Aerospace
HWM
$103B
| $164M | 1.48% |
+7,865,574
| New | +$153M |
|
21
Amdocs
DOX
$6.5B
| $158M | 1.42% |
+2,411,722
| New | +$157M |
|
|
ZAYO
22
DELISTED
Zayo Group Holdings, Inc.
ZAYO
| $157M | 1.41% |
+4,263,039
| New | +$151M |
|
23
FedEx
FDX
$76.3B
| $155M | 1.39% |
+619,832
| New | +$142M |
|
|
NLSN
24
DELISTED
Nielsen Holdings plc
NLSN
| $153M | 1.38% |
+4,204,982
| New | +$160M |
|
25
Microsoft
MSFT
$3.71T
| $152M | 1.37% |
+1,776,798
| New | +$146M |
|
Similar funds
DPAM
CA
ICG
CW
WSTAM
CT
ZCM
CQS
Manning & Napier Group's Q4 2017 Portfolio in Review
Q4 2017 is the first quarter with a 13F filing on record for Manning & Napier Group, which disclosed 322 positions worth $11.1B. Its ten largest holdings account for 28% of the portfolio.
Its largest position is Medtronic: 4,934,563 shares worth $398M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, followed by Technology and Consumer Discretionary.
- Manning & Napier Group's largest Q4 2017 buy was Medtronic: 4,934,563 shares worth $398M.
- Manning & Napier Group's ten largest holdings make up 28% of its $11.1B portfolio in Q4 2017.
- Manning & Napier Group disclosed 322 positions in Q4 2017, its first 13F filing on record.
Based on Manning & Napier Group's 13F filing for Q4 2017, filed 5 Feb 2018.